France Pharmaceuticals

SMAIO SA (ALSMA)

Track

Track

SMAIO SA experienced recent insider trading activity involving director Fabrice Kilfiger, who executed multiple sell orders during early 2026. The most recent transaction occurred on February 18, 2026. These divestments follow a series of sales initiated by the same individual throughout January, reflecting ongoing adjustments to his equity holdings within the organization.
Ticker: ALSMA Exchange: PAR
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.2
Fabrice Kilfiger Administrateur Director
Transaction date
Sale
Price
397.32
Quantity 50,130
Value €2,708,697
3.2
Fabrice Kilfiger Administrateur Director
Transaction date
Sale
Price
261.78
Quantity 87,981
Value €44,759
3.2
Fabrice Kilfiger Administrateur Director
Transaction date
Purchase
Price
288.11
Quantity 94,875
Value €2,333,245
3.2
Fabrice Kilfiger Administrateur Director
Transaction date
Sale
Price
7.54
Quantity 2,855
Value €21,536
3.2
Fabrice Kilfiger Administrateur Director
Transaction date
Sale
Price
7.60
Quantity 500
Value €3,800
3.2
Fabrice Kilfiger Administrateur Director
Transaction date
Sale
Price
8.00
Quantity 173
Value €1,384
3.2
Fabrice Kilfiger Administrateur Director
Transaction date
Sale
Price
7.78
Quantity 1,000
Value €7,775
Jean-Charles Roussouly VP Operations Officer
Transaction date
Purchase
Price
3.30
Quantity 7,676
Value €25,331
Philippe Roussouly Président-Directeur Général Executive Director
Through Sylorus Scientific Société par actions simplifiée, a closely affiliated person
Transaction date
Purchase
Price
3.30
Quantity 13,425
Value €44,302
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-24 2026-02-18 S Sale
3.2
Fabrice Kilfiger

Administrateur

Director
50,130
397.32
€2,708,697 		50,130 397.32 €2,708,697
2026-01-27 2026-01-23 S Sale
3.2
Fabrice Kilfiger

Administrateur

Director
87,981
261.78
€44,759 		87,981 261.78 €44,759
2025-10-03 2025-09-26 B Purchase
3.2
Fabrice Kilfiger

Administrateur

Director
94,875
288.11
€2,333,245 		94,875 288.11 €2,333,245
2025-08-08 2025-07-31 S Sale
3.2
Fabrice Kilfiger

Administrateur

Director
2,855
7.54
€21,536 		2,855 7.54 €21,536
2025-08-08 2025-07-31 S Sale
3.2
Fabrice Kilfiger

Administrateur

Director
500
7.60
€3,800 		500 7.60 €3,800
2025-08-08 2025-07-31 S Sale
3.2
Fabrice Kilfiger

Administrateur

Director
173
8.00
€1,384 		173 8.00 €1,384
2025-08-08 2025-07-31 S Sale
3.2
Fabrice Kilfiger

Administrateur

Director
1,000
7.78
€7,775 		1,000 7.78 €7,775
2023-03-22 2023-03-21 B Purchase
Jean-Charles Roussouly

VP Operations

Officer
7,676
3.30
€25,331 		7,676 3.30 €25,331
2023-03-21 2023-03-16 B Purchase
Philippe Roussouly

Président-Directeur Général

Through Sylorus Scientific Société par actions simplifiée, a closely affiliated person Executive Director
13,425
3.30
€44,302 		13,425 3.30 €44,302
Explore more

More insider trading research around SMAIO SA

More insider trades in France
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe